Authors: Meins, M Piosik, P Schaeren-Wiemers, N Franzoni, S Troncoso, E Kiss, JZ Brosamle, C Schwab, ME Molnar, Z Monard, D

Citation: M. Meins et al., Progressive neuronal and motor dysfunction in mice overexpressing the serine protease inhibitor protease nexin-1 in postmitotic neurons, J NEUROSC, 21(22), 2001, pp. 8830-8841

Authors: Murer, V Spetz, JF Hengst, U Altrogge, LM de Agostini, A Monard, D

Citation: V. Murer et al., Male fertility defects in mice lacking the serine protease inhibitor protease nexin-1, P NAS US, 98(6), 2001, pp. 3029-3033

Authors: Hengst, U Albrecht, H Hess, D Monard, D

Citation: U. Hengst et al., The phosphatidylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors, J BIOL CHEM, 276(1), 2001, pp. 535-540

Authors: Altrogge, LM Monard, D

Citation: Lm. Altrogge et D. Monard, An assay for high-sensitivity detection of thrombin activity and determination of proteases activating or inactivating protease-activated receptors, ANALYT BIOC, 277(1), 2000, pp. 33-45

Authors: Mihailescu, D Kury, P Monard, D

Citation: D. Mihailescu et al., An octamer-binding site is crucial for the activity of an enhancer active at the embryonic met-/mesencephalic junction, MECH DEVEL, 84(1-2), 1999, pp. 55-67

Authors: Rettenberger, PM Oka, K Ellgaard, L Petersen, HH Christensen, A Martensen, PM Monard, D Etzerodt, M Chan, L Andreasen, PA

Citation: Pm. Rettenberger et al., Ligand binding properties of the very low density lipoprotein receptor - Absence of the third complement-type repeat encoded by exon 4 is associated with reduced binding of M-r 40,000 receptor-associated protein, J BIOL CHEM, 274(13), 1999, pp. 8973-8980